News and Stories About clinical trials

We spoke with experts about diversity and equity in clinical trials and patient care.

PanCAN takes center stage as president and CEO discusses clinical trials and more.

Editor’s note: In honor of Black History Month, PanCAN is celebrating the contributions of our community’s Black supporters and the […]
READ MORE

Editor’s note: Today, on National Nurses Day, we are sharing a previously published story about a nurse who works with […]
READ MORE

Awareness of both the risk factors and symptoms of the disease is important.

“I can’t believe it. Reesa, of all people…” When Reesa Levy’s friends and family found out she had pancreatic cancer […]
READ MORE

The 2021 Gastrointestinal (GI) Cancers Symposium recently brought together oncologists, researchers, patients and patient advocates, including the Pancreatic Cancer Action […]
READ MORE

Los estudios clinicos han estado en las noticias recientemente porque son la única manera de poder aprobar nuevos tratamientos para […]
READ MORE

A sports quote became the rallying cry for an Ohio teacher and coach fighting pancreatic cancer.

“Life is basically back to normal.” These are the words of five-year stage IV pancreatic cancer survivor, Lynne Holcomb, of […]
READ MORE

Every day in 2021, 166 Americans will learn that they have pancreatic cancer. That’s 60,430 people who are predicted to […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today’s article describes the complex and changing landscape of clinical […]
READ MORE

When Mike Donaldson was diagnosed with pancreatic cancer in 2014, he was not yet a father. Now, he and his […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today, we kick off the monthlong campaign to bring awareness […]
READ MORE

Get a recap of our World Pancreatic Cancer Day webinar featuring an expert panel discussing the latest in clinical research […]

Adaptive Clinical Trial Design Provides A More Cost Effective, Efficient, and Patient-Centric Approach to Clinical Development Los Angeles, Calif. – […]
READ MORE

We recently announced that our groundbreaking new approach to pancreatic cancer clinical trials – PanCAN’s Precision PromiseSM – is open […]
READ MORE

Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials Los Angeles, Calif. […]
READ MORE

“The standard clinical trial system is not working fast enough for pancreatic cancer patients.” — Julie Fleshman, JD, MBA, PanCAN […]
READ MORE

Editor’s note: “Jeopardy!” host Alex Trebek and former Sen. Harry Reid have publicly mentioned being treated with an experimental immunotherapy […]
READ MORE

Editor’s note: Earlier this year, we featured Steven Merlin’s amazing dedication as a Pancreatic Cancer Action Network (PanCAN) volunteer and […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) recommends clinical trials for pancreatic cancer patients. Right now, though, the coronavirus disease (COVID-19) […]
READ MORE

Editor’s note: Sadly, Adrian Sorrell passed away in June 2020. We are grateful he allowed his story to be shared.  […]
READ MORE

About one in four pancreatic cancer patients have changes in their tumor that suggest certain treatments may work particularly well […]
READ MORE

Editor’s note: This Rare Disease Day, we want to share more about a rare form of pancreatic cancer – pancreatic […]
READ MORE

The American Society of Clinical Oncology (ASCO) released its “Clinical Cancer Advances 2020” report earlier this week – aptly timed […]
READ MORE

Black History Month recognizes and pays tribute to the role African Americans played in shaping U.S. history. While they are […]
READ MORE

“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE

Editor’s note: Sadly, Gina passed away in January 2021. We are so grateful she shared her story to inspire and […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Throughout the month, we are featuring a “Shedding Light on […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today we share the experience of a stage IV pancreatic […]
READ MORE

Editor’s note: During January, Pancreatic Cancer Clinical Trials Awareness Month, we are featuring a “Shedding Light on Clinical Trials” series […]
READ MORE

Editor’s note: Want to be inspired? Keep reading for a new update on Earl Groce, a stage IV pancreatic cancer […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Throughout the month, we will feature a “Shedding Light on […]
READ MORE

For the first time ever, the five-year survival rate for pancreatic cancer has reached double digits. American Cancer Society’s Cancer […]
READ MORE

Today the U.S. Food and Drug Administration (FDA) approved the targeted therapy Lynparza® (olaparib) for the treatment of patients who […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

The results from two phase III clinical trials for pancreatic cancer patients were recently announced. Both Lilly’s SEQUOIA and Halozyme’s […]
READ MORE

Clinical trials are necessary to determine whether a drug or treatment combination is safe, effective and an improvement over the […]
READ MORE

When talking to your doctor about pancreatic cancer treatment, it can be hard to know what questions to ask. Developing […]
READ MORE

It’s Cancer Immunotherapy Month. Here, we discuss immunotherapy and pancreatic cancer.

Every pancreatic tumor – and every pancreatic cancer patient – is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends […]
READ MORE

This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has brought 40,000 oncologists and other cancer experts from around […]
READ MORE

A new treatment combination – combining chemotherapy and radiation therapy with a common blood pressure drug – has shown promise […]
READ MORE

The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE

The name Earl Groce may sound familiar to you. In January 2018, the then two-and-a-half-year survivor lent his voice during […]
READ MORE

Editor’s Note: In honor of National Minority Health Month, we would like to shed some light on the issues of […]
READ MORE

On April 3, the Pancreatic Cancer Action Network’s (PanCAN) associate director of clinical initiatives, Cassadie Moravek, joined other patient advocacy […]
READ MORE

Editor’s note: In this Washington Post article, Nathaniel Brooks Horwitz wrote about his experience launching biopharmaceutical company Nivien Therapeutics in […]
READ MORE

“There is no way to sugarcoat the fact that pancreatic cancer is very difficult to treat,” begins an article recently […]
READ MORE

It’s African-American History Month, which pays tribute to generations of African-Americans who struggled with adversity to achieve full citizenship in […]
READ MORE

Do you ever see scientific or medical headlines that sound too good to be true? Ask these questions to help […]
READ MORE

The Pancreatic Cancer Action Network’s PanCAN Patient Services Case Managers hear many questions and concerns from patients and caregivers about […]
READ MORE

A large group of Pancreatic Cancer Action Network (PanCAN) leadership and Scientific and Medical Affairs staff are attending the 2019 […]
READ MORE

Clinical trials are developed to answer certain research questions. To get the right information to answer those questions, a trial […]
READ MORE

On Clinical Trials Day, get the facts about this important treatment option.

January is National Pancreatic Cancer Clinical Trials Awareness Month. Pancreatic cancer patients who participate in clinical research have better outcomes. […]
READ MORE

Editor’s note: Today’s edition of the 2018 Year in Review series features the 10 most popular news stories on the […]
READ MORE

Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE

Editor’s note: Michael Curran, PhD, is a 2018 Pancreatic Cancer Action Network (PanCAN) Translational Research Grant recipient. He is an […]
READ MORE

Editor’s note: Sadly, Gail Bamer died in July 2019. We are grateful to her for allowing her story to be […]
READ MORE

Did you know there are more than 180 different pancreatic cancer clinical trials currently enrolling patients in the United States? […]
READ MORE

We’re sharing a basic overview of clinical trials so you can brush up on your knowledge, get the truth about common misconceptions, […]
READ MORE

Before Allison Lippman of Dallas met her now-husband, she was not convinced she wanted to date anyone. “I was turning […]
READ MORE

It is important to know all your treatment options at every stage of your pancreatic cancer diagnosis. Here are five […]
READ MORE

Editor’s note: You may have heard breakthrough news that came out of the American Society of Clinical Oncology (ASCO) Annual […]
READ MORE

On day four of the American Society of Clinical Oncology (ASCO) Annual Meeting, results of two critically important phase III […]
READ MORE

Editor’s note: April is National Minority Health Month. This blog, entitled “Diverse Patient Participation Crucial for New Treatment Options,” has […]
READ MORE

Editor’s note: Today is National Doctors’ Day, and we are celebrating the critical roles of various specialists in the diagnosis […]
READ MORE

In June 2014, David Wingo went to his doctor about abdominal pain. While investigating the pain, his doctor noticed a […]
READ MORE

Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical trial. […]
READ MORE

“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE

The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) took place earlier this week in Berlin. The […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) is excited to launch Precision PromiseSM in 2019. Precision Promise is the first adaptive […]
READ MORE

Today, the U.S. Food & Drug Administration (FDA) approved Lutathera® (lutetium-177 (177Lu)-Dotatate) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), […]
READ MORE

In September 2015, Earl Groce returned home to North Carolina after driving 5,500 miles cross-country for his first trip to […]
READ MORE

Too few pancreatic cancer patients are in clinical trials. Diversity is critical.

The Pancreatic Cancer Action Network Urges All Pancreatic Cancer Patients to Consider Clinical Trial Enrollment Pancreatic Cancer Patients Who Participate […]
READ MORE

Richard Blish, a nine-year pancreatic cancer survivor, was diagnosed in 2009 with a marginally resectable tumor and less than a […]
READ MORE

This year during National Pancreatic Cancer Clinical Trials Awareness Month, we Demand Better. For Patients. For Survival. Matt Wilson, a […]
READ MORE

January is National Pancreatic Cancer Clinical Trials Awareness Month. Thanks to the community’s participation last year, the Pancreatic Cancer Action […]
READ MORE

At the end of every year, Science magazine announces a Breakthrough of the Year – a discovery that revolutionized the […]
READ MORE

Choosing a clinical trial on your own can be challenging. Some trial listings are out-of-date, and others require looking through […]
READ MORE

Published in the Journal of Gastrointestinal Cancer, a recent survey of 150 oncologists showed a lack of compliance with evidence-based […]
READ MORE

Pancreatic cancer is difficult to treat. There are a few standard treatments, but there are additional options that we encourage […]
READ MORE

An article published yesterday in Newsweek describes a European analysis that found cancer drugs are being approved without adequate evidence […]
READ MORE

A pancreatic cancer diagnosis and the decisions that come after can feel overwhelming. But getting organized can help patients and […]
READ MORE

A news article originally published in USA Today explored the relatively low number of Hispanics who enroll in clinical trials […]
READ MORE

The so-called breast cancer genes BRCA1 and BRCA2 were originally found to increase a woman’s risk of breast cancer when […]
READ MORE

The final episode of a three-part documentary, First in Human, aired on Aug. 24, on Discovery. The six-hour series provided a […]
READ MORE

The second episode of the three-part Discovery documentary on clinical trials, First in Human, follows the gripping story of three […]
READ MORE

The first episode of a three-part documentary, First in Human, debuted Aug. 10, on Discovery. The six-hour series provides a […]
READ MORE

Clinical trials are critical to advance treatment options, and pancreatic cancer patients who participate in clinical research have better outcomes. […]
READ MORE

Editor’s note: Keytruda was the first cancer drug approved to treat any solid tumor – anywhere in the body – […]
READ MORE

In 2009, Jennifer Tseng, MD, and her team were scouring a National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End results […]
READ MORE

CBS “Sunday Morning” aired a special titled, “Beyond Cancer,” featuring the latest news on research, diagnosis and treatments, plus stories […]
READ MORE

Meet Vincent Picozzi, Jr., MD, director of the pancreaticobiliary program at the Floyd & Delores Jones Cancer Institute at Virginia […]
READ MORE

The online healthcare publisher OncLive often features interviews with doctors and researchers who specialize in pancreatic cancer. This week they […]
READ MORE

Throughout National Pancreatic Cancer Clinical Trials Awareness Month, you’ve received a lot of information. We’ve shared firsthand survivor stories, provided […]
READ MORE

Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical […]
READ MORE

Making treatment decisions may be overwhelming. We want to make sure you have the information you need, every step of […]
READ MORE

Why do people not participate in clinical trials? Some assume it’s a scary process involving being “experimented on” like you […]
READ MORE

Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical […]
READ MORE

It can be difficult to keep track of the different treatment options available for pancreatic cancer, and many patients are […]
READ MORE

Olympians aren’t the only people taking home medals. We are proud to have won bronze for our Clinical Trial Finder […]
READ MORE

Fighting pancreatic cancer is no easy task. That’s why the Pancreatic Cancer Action Network is excited to join forces with […]
READ MORE

A rigorous analysis of 25 years’ worth of pancreatic cancer clinical trial data was published on June 6, 2016, in […]
READ MORE

Preliminary results from an early-phase immunotherapy clinical trial suggest that an innovative treatment could be effective for patients with locally-advanced or borderline-resectable pancreatic cancer.

Pancreatic Cancer Patients Encouraged to Consider Clinical Trial Enrollment MANHATTAN BEACH, Calif. – (January 6, 2016) — With no effective screening […]
READ MORE